Brisket Disease / High Altitude Disease (cattle)

Brisket disease, also known as high altitude disease, is a condition affecting cattle at high elevations characterized by right-sided heart failure secondary to pulmonary hypertension. The condition develops when cattle are unable to adequately adapt their cardiovascular systems to the reduced oxygen availability at high altitudes. Chronic hypoxia triggers sustained pulmonary vasoconstriction, which increases resistance to blood flow through the lungs and forces the right ventricle to work progressively harder. Eventually, the right ventricle fails under this increased workload, leading to systemic venous congestion and the characteristic subcutaneous edema of the brisket region that gives the disease its common name.

Brisket disease primarily affects cattle maintained at elevations above five thousand feet, with increasing prevalence at higher altitudes. The condition is well recognized in the mountainous regions of the western United States, South America, and other high-altitude cattle-producing areas worldwide. While any cattle can be affected, genetic variation in susceptibility means that some individuals and bloodlines are much more vulnerable than others. The condition can develop in cattle born at high altitude or in animals moved from low to high elevations. Young growing cattle and pregnant or lactating cows face particular risk due to their higher metabolic oxygen demands.

The economic impact of brisket disease is substantial in high-altitude cattle operations. Mortality rates in susceptible populations can exceed five percent, with some herds experiencing much higher losses during challenging years. Beyond direct mortality, the disease causes significant production losses through reduced weight gain, decreased reproductive performance, and premature culling of affected animals. The need to select against susceptibility affects breeding program flexibility. Operations at extreme altitudes may face chronic challenges that influence operational viability and require ongoing genetic management to maintain adapted herds.

Treatability of brisket disease varies depending on disease stage and practical circumstances. Early cases often respond to relocation to lower altitude, where reduced pulmonary vascular resistance allows cardiac function to improve. However, animals with advanced cardiac damage may not fully recover even at low elevation. Prevention through genetic selection for low pulmonary arterial pressure represents the most effective long-term management strategy. Understanding the genetic and physiological basis of brisket disease has enabled development of selection tools that have significantly reduced disease incidence in managed herds while maintaining productivity.

The primary cause of brisket disease is the physiological response to chronic hypoxia at high altitude. As elevation increases, atmospheric pressure decreases, reducing the partial pressure of oxygen in inspired air. At five thousand feet elevation, oxygen availability is approximately eighty-three percent of sea level values, declining to only seventy percent at ten thousand feet. The bovine lung responds to this reduced oxygen by constricting pulmonary blood vessels, a mechanism that in acute situations helps match blood flow to better-ventilated lung regions. However, when this vasoconstriction becomes chronic and generalized, pulmonary vascular resistance increases dramatically, imposing an unsustainable workload on the right ventricle.

Genetic predisposition is the critical factor determining which cattle develop brisket disease at any given altitude. Pulmonary arterial pressure, the key physiological parameter reflecting pulmonary vascular resistance, is highly heritable in cattle. Some animals maintain relatively low pulmonary pressures even at high altitude, while others develop markedly elevated pressures that predispose to right heart failure. This genetic variation explains why some cattle thrive at elevations where others succumb to brisket disease. Heritability estimates for pulmonary arterial pressure range from approximately forty to sixty percent, indicating strong genetic control that responds to selection.

Environmental and management factors interact with genetic susceptibility to determine disease occurrence. The most obvious environmental factor is altitude itself, with higher elevations imposing greater hypoxic stress. However, other factors at any given altitude can influence disease expression. Cold temperatures increase metabolic rate and oxygen demand, exacerbating hypoxic stress. Respiratory diseases that compromise lung function reduce oxygen uptake and worsen pulmonary hypertension. Nutritional status affects cardiovascular capacity and oxygen-carrying ability. Pregnancy and lactation increase metabolic demands and may precipitate disease in marginally adapted animals.

Risk factors for brisket disease include both animal and environmental characteristics. Cattle with inherently high pulmonary arterial pressure are at greatest risk, regardless of altitude. Young growing animals face higher metabolic oxygen demands during rapid growth phases. Cattle moved from low to high altitude face acute adaptation challenges and may develop disease more rapidly than native cattle. Animals with respiratory disease, anemia, or other conditions affecting oxygen delivery have increased susceptibility. Bulls working at high altitude face exercise demands that stress the cardiovascular system. Pregnant cows, particularly those carrying twins, have elevated metabolic requirements.

The pathophysiology of brisket disease involves progressive right heart failure from sustained pulmonary hypertension. Chronic hypoxic pulmonary vasoconstriction increases pulmonary vascular resistance, requiring higher right ventricular pressures to maintain adequate cardiac output. The right ventricle initially compensates through hypertrophy, thickening its muscular wall to generate increased pressure. Over time, the compensatory mechanisms become insufficient, and the right ventricle dilates and fails. Elevated right-sided pressures cause systemic venous congestion, with fluid accumulating in dependent tissues. The brisket area, as a dependent site with loose subcutaneous tissue, characteristically develops marked edema.

Early warning signs of brisket disease may be subtle and easily overlooked in range cattle with limited handling. Affected animals often show reduced activity levels compared to herdmates, with less grazing and more time spent resting. Mild exercise intolerance may be noted, with affected cattle falling behind the herd during movement and recovering slowly after exertion. Respiratory rate at rest may be slightly increased. Some cattle show mild coughing. Early weight loss or failure to gain appropriately may precede more obvious signs. Attentive observation during routine handling provides opportunities to identify cattle showing early changes before progression to obvious disease.

Symptoms in cattle progress through recognizable stages as the disease advances. Initially, cattle may simply appear unthrifty without specific abnormalities. As pulmonary hypertension worsens, exercise intolerance becomes more pronounced. Cattle begin to show visible respiratory effort, with increased respiratory rate and depth. The hallmark sign of subcutaneous edema develops, typically first appearing in the submandibular region (bottle jaw) and brisket area. This edema is cool, non-painful, and pitting in character, distinguishing it from inflammatory swellings. Jugular vein distension becomes apparent as right heart failure progresses.

Behavioral changes in affected cattle reflect their declining cardiovascular capacity. Animals spend increasing amounts of time lying down and are reluctant to rise and move with the herd. Affected cattle may seek shade or water more frequently. Appetite typically decreases as condition worsens, contributing to progressive weight loss. Cattle may adopt postures that appear to ease breathing, including extended head and neck position. Social interactions diminish as animals lack energy for normal herd behavior. The combination of lethargy and respiratory signs often prompts owner recognition that something is seriously wrong.

Physical signs of brisket disease become increasingly obvious as heart failure develops. Subcutaneous edema extends beyond the brisket to include the ventral abdomen, udder or prepuce, and distal limbs. Jugular veins are prominently distended and may show abnormal pulsation due to tricuspid regurgitation. Respiratory rate is elevated, and breathing may appear labored. Mucous membranes may appear darker than normal due to poor oxygenation. Heart rate is often elevated, and cardiac auscultation may reveal murmurs from valvular insufficiency. Abdominal distension may indicate ascites from hepatic congestion.

Symptom progression in brisket disease typically occurs over weeks to months, though acute deterioration can occur with additional stresses. Early mild signs gradually intensify as cardiac compensation fails. Edema steadily increases in extent and severity. Respiratory distress worsens, particularly with any exertion. Weight loss becomes pronounced despite continued feed availability. Animals become progressively weaker and may have difficulty rising. In terminal stages, cattle may remain recumbent and show signs of severe distress. The course can be accelerated by concurrent illness, extreme weather, or continued exposure to altitude.

Emergency symptoms requiring immediate intervention include severe respiratory distress, inability to rise, extreme edema causing tissue compromise, or signs of cardiovascular collapse. Cattle showing these signs are in critical condition and have very poor prognosis. Immediate removal to low altitude, if geographically feasible, offers the only chance for survival of advanced cases, but many animals with severe disease do not survive transport. In practical circumstances, humane euthanasia may be the most appropriate option for cattle with end-stage brisket disease to prevent prolonged suffering.

Clinical examination for suspected brisket disease focuses on identifying the characteristic signs of right heart failure. Assessment of body condition and comparison with herdmates reveals weight loss or poor condition. Observation of respiratory rate and effort at rest establishes baseline respiratory status. Examination for subcutaneous edema in typical locations confirms fluid accumulation. Palpation distinguishes the cool, pitting edema of heart failure from warm inflammatory swellings. Cardiac auscultation evaluates heart rate, rhythm, and presence of murmurs. Jugular vein assessment for distension and abnormal pulsation provides information about right heart pressures and function.

Diagnostic tests for brisket disease include measurement of pulmonary arterial pressure, which is the definitive diagnostic and screening test. This procedure involves passing a catheter through the jugular vein into the pulmonary artery to directly measure pressure. While invasive, the technique is well established and can be performed in field conditions by experienced practitioners. Pressures above approximately forty-two millimeters of mercury at elevations above five thousand feet indicate increased susceptibility and disease risk, while pressures above approximately forty-nine millimeters of mercury indicate established pulmonary hypertension. Echocardiography, where available, provides noninvasive assessment of cardiac structure and function, including right ventricular dimensions and estimates of pulmonary pressure.

Differential diagnosis for brisket disease includes other causes of subcutaneous edema and poor condition in cattle. Protein-losing conditions, including parasitism and chronic hepatic or renal disease, can cause edema without primary cardiac involvement. Hardware disease (traumatic reticuloperitonitis) with pericardial involvement may present similarly. Other cardiac conditions including bacterial endocarditis and congenital heart defects can cause right heart failure at any elevation. Lymphatic obstruction from neoplasia or other causes may produce regional edema. The combination of altitude exposure, characteristic clinical signs, and elevated pulmonary arterial pressure establishes the diagnosis.

Herd-level diagnostics are highly relevant for brisket disease management because the condition reflects population genetics interacting with environmental exposure. Pulmonary arterial pressure testing of the herd or representative sample identifies susceptible individuals and characterizes population risk. Testing yearlings provides information for breeding decisions before animals enter production. Evaluation of breeding bulls is particularly important because one susceptible sire can affect many offspring. Analysis of historical disease patterns helps predict which environments and seasons pose greatest risk. Comprehensive herd assessment guides development of genetic selection and management programs to reduce disease incidence.

Emergency treatment for cattle with advanced brisket disease focuses on alleviating cardiovascular distress while preparing for definitive management. Diuretic therapy, typically with furosemide, helps reduce fluid accumulation and ease respiratory and cardiovascular burden. Oxygen supplementation, while impractical in most field situations, would theoretically benefit affected animals by reducing hypoxic pulmonary vasoconstriction. Anti-inflammatory medications may provide some symptomatic relief. Most importantly, planning for immediate transport to lower altitude should begin if the animal's value warrants treatment and transport is feasible. Animals in extreme distress may require euthanasia to prevent prolonged suffering.

Medical management of brisket disease has limited effectiveness compared to environmental intervention. Diuretics can temporarily reduce edema and provide symptomatic relief but do not address the underlying pulmonary hypertension. Cardiac glycosides have been used with limited benefit. Vasodilators that might reduce pulmonary vascular resistance in other conditions have not proven effective for brisket disease in cattle. The fundamental problem is the mismatch between the animal's genetically determined cardiovascular response and the environmental oxygen availability, which medication cannot correct. Drug therapy may provide temporary stabilization but is not curative. Any medications used in cattle must be administered with attention to withdrawal times and food safety considerations, and treatment decisions should involve veterinary consultation.

Environmental management through relocation to lower altitude is the primary and most effective treatment for brisket disease. Reducing altitude exposure decreases hypoxic stress and allows pulmonary vasoconstriction to resolve. Animals relocated early in disease course, before severe cardiac damage has occurred, often show marked improvement within days to weeks at lower elevation. Pulmonary arterial pressures typically decrease significantly within the first week of descent. However, the practical challenges of relocation are substantial, including transportation logistics, availability of low-altitude facilities, and the stress of transport on already compromised animals. Some affected animals do not survive the journey to lower elevation.

Supportive care for cattle with brisket disease includes minimizing additional stresses that could worsen cardiovascular demands. Affected animals should be kept calm and handled gently to avoid excitement. Provision of readily accessible feed and water reduces exertion requirements. Shelter from extreme temperatures, particularly cold, helps reduce metabolic oxygen demand. Separation from aggressive herdmates prevents competition stress. Monitoring for concurrent illness allows prompt treatment of respiratory infections or other conditions that could exacerbate hypoxia.

Long-term management following brisket disease recovery depends on residual cardiac function. Animals that fully recover after early intervention may return to production at low altitude. However, recovered animals remain genetically susceptible and will likely develop disease again if returned to high altitude. Culling from the breeding herd is generally recommended to prevent transmission of susceptibility genes to offspring. Some ranchers maintain recovered animals at low-altitude facilities for feeding or limited production rather than returning them to high-altitude operations.

Treatment decisions for brisket disease must balance economic considerations against welfare concerns. The cost of transport, medical care, and maintaining affected animals at low altitude can be substantial. Commercial cattle may not justify treatment expenses, making early culling or euthanasia the practical choice. Valuable breeding stock may warrant treatment attempts, though breeding use of recovered animals is inadvisable. The welfare of affected animals should remain paramount, with humane euthanasia chosen when quality of life cannot be maintained or when treatment is not economically feasible.

Recovery timeline for cattle with brisket disease depends on disease severity at the time of altitude reduction. Animals identified and relocated early, with minimal cardiac damage, often show dramatic improvement within seven to fourteen days at lower elevation. Pulmonary arterial pressures begin declining within hours of descent and may normalize within one to two weeks. Resolution of edema follows as right heart function improves. Animals with more advanced disease and established cardiac changes recover more slowly and may never fully return to normal cardiovascular function. Complete recovery, when it occurs, may require several weeks to months.

Post-treatment care following descent from high altitude includes monitoring for improvement and detecting any complications. Serial assessment of respiratory rate, heart rate, and edema status tracks recovery progress. Animals should remain in a low-stress environment during recovery. Nutritional support helps rebuild body condition lost during illness. Observation for signs of concurrent illness or secondary complications ensures prompt intervention if problems arise. Gradual return to normal activity as condition improves allows assessment of exercise tolerance.

Prognosis factors for brisket disease recovery relate primarily to disease severity and duration before treatment. Animals detected early with mild to moderate edema have favorable prognosis with prompt altitude reduction. Severe edema, marked respiratory distress, and signs of advanced heart failure indicate poorer prognosis. Animals that fail to show improvement within one to two weeks of descent likely have irreversible cardiac damage. Individual variation in response exists, with some animals recovering better than expected while others fail to improve despite seemingly similar disease severity.

Return to production considerations for brisket disease survivors must address both practical and genetic concerns. Recovered animals cannot return to high altitude without recurring disease, limiting their use in many operations. Production at low altitude may continue if cardiac function has adequately recovered. However, the most important consideration is genetic: recovered animals carry susceptibility genes and should not be used for breeding in herds intended for high-altitude use. Even at low altitude, breeding use should be discouraged to avoid spreading susceptibility genes. The most appropriate disposition for recovered commercial cattle is often feeding for harvest at an appropriate time.

Vaccination does not play a role in brisket disease prevention, as the condition is not caused by infectious agents. However, vaccination against respiratory diseases that could compromise lung function and worsen hypoxic stress is part of comprehensive herd health management at high altitude. Maintaining immunity against viral and bacterial respiratory pathogens reduces the likelihood of pulmonary disease that could precipitate brisket disease in marginally adapted animals. Vaccination programs should be developed with veterinary input based on regional disease risks.

Biosecurity measures have limited direct application to brisket disease prevention but remain important for overall herd health. Preventing introduction of respiratory pathogens through quarantine and testing of incoming animals protects against lung disease that could exacerbate altitude stress. General biosecurity practices that maintain herd health reduce concurrent disease challenges. Purchasing animals from herds with established low pulmonary arterial pressure is a form of genetic biosecurity that reduces susceptibility introduction.

Genetic selection is the cornerstone of brisket disease prevention and represents one of the most successful applications of applied genetics in beef cattle production. Pulmonary arterial pressure testing allows identification and culling of high-pressure animals before they contribute offspring to the herd. Selection for low pulmonary arterial pressure has dramatically reduced brisket disease incidence in herds implementing consistent testing programs. Testing of replacement heifers and young bulls identifies susceptible animals early. Preferential use of low-pressure bulls, either through natural service or artificial insemination, improves population adaptation over generations.

Management practices for brisket disease prevention complement genetic selection. Avoiding movement of unadapted cattle to high altitude reduces disease in immigrant animals. Gradual altitude acclimatization, when feasible, may reduce acute stress compared to immediate exposure. Managing pregnant and lactating cattle at relatively lower elevations within the operation reduces disease during high-demand physiological states. Minimizing stress through good handling and adequate nutrition supports cardiovascular function. Avoiding exposure of susceptible cattle to additional stressors, including extreme cold and respiratory disease, reduces the likelihood that marginal animals develop clinical disease.

Screening and testing protocols are essential components of brisket disease prevention programs. Annual pulmonary arterial pressure testing of yearling cattle identifies susceptible animals before breeding decisions are made. Testing of all potential breeding bulls is particularly critical given their genetic impact on future generations. Some operations test purchased animals before allowing them to join the herd at high altitude. Recording and analysis of test results over time tracks genetic progress and guides selection intensity. Commercial testing services and research programs provide access to standardized protocols and reference values.

Daily management of cattle at high altitude requires awareness of brisket disease risk and vigilance for early signs. Regular observation of the herd identifies animals showing decreased activity, respiratory changes, or early edema. Cattle with known elevated pulmonary arterial pressure require particular attention. Providing adequate nutrition to support metabolic demands without excessive body condition is important. Ensuring easy access to water reduces exertion requirements. Calm handling during any necessary procedures minimizes stress-related cardiovascular demands. Documenting observations supports recognition of animals with developing problems.

Housing and environmental management at high altitude should account for the additional cardiovascular stress these environments impose. Providing wind protection and shelter reduces cold stress that increases metabolic demand. Avoiding situations that require cattle to travel long distances or climb steep terrain reduces exertion requirements. Water and mineral sources should be conveniently located. During extreme weather, additional attention to susceptible animals may be warranted. Where possible, managing cattle at the lower end of elevation ranges within an operation reduces hypoxic stress.

Herd health programs for high-altitude cattle operations must address brisket disease as a central concern. Pulmonary arterial pressure testing should be integrated into routine management for all cattle entering the breeding pool. Records of test results, disease occurrence, and sire/dam information support selection decisions. Respiratory disease prevention and prompt treatment programs reduce complications that exacerbate brisket disease risk. Nutrition programs optimized for high-altitude conditions support cardiovascular health. Veterinary consultation helps develop comprehensive programs addressing the unique challenges of high-altitude cattle production.

Record keeping for brisket disease management supports both individual animal decisions and genetic progress. All pulmonary arterial pressure test results should be recorded with animal identification, test date, age, and altitude. Disease occurrence, including severity and outcome, should be documented. Pedigree information links individuals to sires and dams for genetic analysis. Production records allow assessment of whether selection for low pulmonary pressure affects other traits. Accumulated records over years provide data for evaluating program effectiveness and guiding future selection intensity.

Economic considerations in high-altitude cattle production must account for brisket disease as an ongoing management cost. Testing expenses represent a regular investment in prevention. Loss of susceptible animals through culling or death affects herd economics. Potential limitations on genetic sources if adaptation is prioritized may affect other traits. However, the costs of brisket disease in unmanaged herds, including mortality, production losses, and treatment expenses, generally far exceed prevention program costs. Economic modeling can help operations optimize selection intensity and management practices for their specific circumstances.

High-risk breeds for brisket disease are not clearly defined by breed per se, but rather by adaptation history and selection background. Cattle from breeds with long histories of use at high altitude, particularly South American breeds such as the Criollo, often show better adaptation than breeds developed at lower elevations. Among British and Continental breeds commonly used in North American beef production, considerable variation in susceptibility exists both within and between breeds. Individual breed associations have generally not established population-level pulmonary arterial pressure data, making breed comparisons difficult. The most important factor is the specific genetic background of individual animals rather than breed identity.

Production type considerations influence brisket disease management strategies. Beef cattle operations in mountainous regions face the greatest challenges and have developed the most extensive prevention programs. Dairy cattle are rarely maintained at elevations where brisket disease is common, reducing concern for that production sector. Within beef operations, cow-calf producers must emphasize genetic selection in breeding herds, while stocker and finishing operations may manage disease primarily through avoiding high-altitude exposure of unadapted cattle. Seedstock producers serving high-altitude markets bear particular responsibility for testing and selection to provide adapted genetics.

Genetic selection and testing have transformed brisket disease management over the past several decades. Research beginning in the mid-twentieth century established the heritability of pulmonary arterial pressure and developed practical testing methods. Breed associations and research institutions have provided testing services that enable widespread selection. Estimated breeding values for pulmonary arterial pressure are available in some populations, improving selection accuracy. Genomic research has identified genetic markers associated with pulmonary arterial pressure, with potential for genomic selection tools in the future. Continued genetic improvement through selection remains the most effective approach to reducing brisket disease in high-altitude cattle populations.

Commonly co-occurring conditions with brisket disease include other manifestations of high-altitude stress and complications of right heart failure. Respiratory infections at high altitude may precipitate or worsen brisket disease through further compromise of oxygen uptake. Other hypoxia-related syndromes, while not as common as brisket disease in adult cattle, may affect calves at extreme elevations. Secondary liver congestion from right heart failure can cause hepatic dysfunction. Ascites may develop as part of generalized fluid accumulation. Poor nutrition and weight loss from reduced feed intake create additional health challenges. Concurrent management of these related conditions is often necessary.

Conditions with similar symptoms to brisket disease require differentiation through careful clinical and, when possible, diagnostic evaluation. Other causes of dependent edema in cattle include hypoproteinemia from parasitism, liver disease, or renal disease. Hardware disease with pericardial involvement can cause right heart failure and similar signs. Lymphatic obstruction from neoplasia or other causes may produce regional edema. Heart failure from causes other than brisket disease, including congenital defects and acquired cardiac diseases, presents similarly. The combination of altitude exposure, characteristic findings, and elevated pulmonary arterial pressure distinguishes brisket disease from these alternatives.

Complications and sequelae of brisket disease extend beyond the primary cardiovascular syndrome. Chronic right heart failure leads to hepatic congestion and potentially chronic liver damage. Prolonged tissue hypoxia may cause dysfunction in multiple organ systems. Animals that survive with residual cardiac damage may have reduced productivity and shortened productive lives. The genetic implications of brisket disease extend to offspring, as susceptibility genes are transmitted to future generations if affected animals breed. Recognition of these broader implications emphasizes the importance of genetic selection for prevention rather than relying on treatment of affected individuals.